CRESEMBA is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Astellas Pharma Us, Inc.. The primary component is Isavuconazonium Sulfate.
Product ID | 0469-0420_034e698e-c634-4372-9a9a-89ca83dc0a80 |
NDC | 0469-0420 |
Product Type | Human Prescription Drug |
Proprietary Name | CRESEMBA |
Generic Name | Isavuconazonium Sulfate |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2015-03-06 |
Marketing Category | NDA / NDA |
Application Number | NDA207501 |
Labeler Name | Astellas Pharma US, Inc. |
Substance Name | ISAVUCONAZONIUM SULFATE |
Active Ingredient Strength | 40 mg/mL |
Pharm Classes | Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2015-03-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA207501 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-03-06 |
Ingredient | Strength |
---|---|
ISAVUCONAZONIUM SULFATE | 74.4 mg/mL |
SPL SET ID: | 8f7f73b8-586a-4df0-935f-fecd4696c16c |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0469-0420 | CRESEMBA | isavuconazonium sulfate |
0469-0520 | CRESEMBA | isavuconazonium sulfate |
0469-2860 | CRESEMBA | isavuconazonium sulfate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CRESEMBA 87380656 5363262 Live/Registered |
Astellas US LLC 2017-03-22 |
CRESEMBA 85967909 4532336 Live/Registered |
Astellas Pharma Inc. 2013-06-24 |